Patent Application
20210309952
Cellular communication has been studied extensively by scientists, clinicians and engineers, as it is a critical component in development and disease. In order to communicate, cells emit extracellular signaling molecules (e.g., cytokines and growth factors), which are recognized by surface receptors on nearby cells. This communication regulates if a cell will proliferate (increase in number), migrate, or undergo apoptosis (cell death). Understanding cell-cell communication is especially critical in diseases such as cancer. Solid tumors are composed of multiple cell types (cancer cells, endothelial cells, immune cells, adipocytes, fibroblasts) that can contribute to cancer progression and resistance to therapy. It is known that cancer progression and resistance to therapeutic intervention can arise from communication between cancer cells and the surrounding non-cancer cell populations.
Further understanding of this relationship can lead to developing improved adjuvant breast cancer therapies. Traditional approaches to co-culture two different types of cells are done by direct cell contact using a permeable insert (such as a Transwell® assay). This technology involves plating cells above and below a semi-permeable membrane to allow for secreted factors to diffuse to each cell line. One constraint of this current method is that the technique does not yield enough cells for thorough cellular analysis such as PCR or Western Blot. Another difficulty is successfully separating cell lines after co-culture. It can also be challenging to overcome these problems while still achieving adequate cell line communication. These needs and other needs are satisfied by the present disclosure.
Embodiments of the present disclosure provide cell plate inserts, systems for cell co-culture, and the like.
An embodiment of the present disclosure includes cell plate inserts that include an interior lip and legs on a bottom side. The cell plate inserts can have a diameter that provides a snug fit within a cell plate or well.
The cell plate inserts can include a cell support membrane disposed on an interior lip of the cell plate insert.
An embodiment of the present disclosure includes systems for cell co-culture, including a cell plate insert as above.
Other compositions, apparatus, methods, features, and advantages will be or become apparent to one with skill in the art upon examination of the following drawings and detailed description. It is intended that all such additional compositions, apparatus, methods, features and advantages be included within this description, be within the scope of the present disclosure, and be protected by the accompanying claims.
Further aspects of the present disclosure will be more readily appreciated upon review of the detailed description of its various embodiments, described below, when taken in conjunction with the accompanying drawings. The components in the drawings are not necessarily to scale, emphasis instead being placed upon clearly illustrating the principles of the present disclosure.
The drawings illustrate only example embodiments and are therefore not to be considered limiting of the scope described herein, as other equally effective embodiments are within the scope and spirit of this disclosure. The elements and features shown in the drawings are not necessarily drawn to scale, emphasis instead being placed upon clearly illustrating the principles of the embodiments. Additionally, certain dimensions may be exaggerated to help visually convey certain principles.
Before the present disclosure is described in greater detail, it is to be understood that this disclosure is not limited to particular embodiments described, and as such may, of course, vary. It is also to be understood that the terminology used herein is for the purpose of describing particular embodiments only, and is not intended to be limiting, since the scope of the present disclosure will be limited only by the appended claims.
Where a range of values is provided, it is understood that each intervening value, to the tenth of the unit of the lower limit unless the context clearly dictates otherwise, between the upper and lower limit of that range and any other stated or intervening value in that stated range, is encompassed within the disclosure. The upper and lower limits of these smaller ranges may independently be included in the smaller ranges and are also encompassed within the disclosure, subject to any specifically excluded limit in the stated range. Where the stated range includes one or both of the limits, ranges excluding either or both of those included limits are also included in the disclosure.
Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this disclosure belongs. Although any methods and materials similar or equivalent to those described herein can also be used in the practice or testing of the present disclosure, the preferred methods and materials are now described.
As will be apparent to those of skill in the art upon reading this disclosure, each of the individual embodiments described and illustrated herein has discrete components and features which may be readily separated from or combined with the features of any of the other several embodiments without departing from the scope or spirit of the present disclosure. Any recited method can be carried out in the order of events recited or in any other order that is logically possible.
Embodiments of the present disclosure will employ, unless otherwise indicated, techniques of chemistry, biology, and the like, which are within the skill of the art.
The following examples are put forth so as to provide those of ordinary skill in the art with a complete disclosure and description of how to perform the methods and use the apparatus and methods disclosed and claimed herein. Efforts have been made to ensure accuracy with respect to numbers (e.g., amounts, temperature, etc.), but some errors and deviations should be accounted for. Unless indicated otherwise, parts are parts by weight, temperature is in ° C., and pressure is at or near atmospheric. Standard temperature and pressure are defined as 20° C. and 1 atmosphere.
Before the embodiments of the present disclosure are described in detail, it is to be understood that, unless otherwise indicated, the present disclosure is not limited to particular materials, reagents, reaction materials, manufacturing processes, or the like, as such can vary. It is also to be understood that the terminology used herein is for purposes of describing particular embodiments only, and is not intended to be limiting. It is also possible in the present disclosure that steps can be executed in different sequence where this is logically possible.
It must be noted that, as used in the specification and the appended claims, the singular forms “a,” “an,” and “the” include plural referents unless the context clearly dictates otherwise.
As used herein, the following terms have the meanings ascribed to them unless specified otherwise. In this disclosure, “consisting essentially of” or “consists essentially” or the like, when applied to methods and compositions encompassed by the present disclosure refers to compositions like those disclosed herein, but which may contain additional structural groups, composition components or method steps (or analogs or derivatives thereof as discussed above). Such additional structural groups, composition components or method steps, etc., however, do not materially affect the basic and novel characteristic(s) of the compositions or methods, compared to those of the corresponding compositions or methods disclosed herein. “Consisting essentially of” or “consists essentially” or the like, when applied to methods and compositions encompassed by the present disclosure have the meaning ascribed in U.S. Patent law and the term is open-ended, allowing for the presence of more than that which is recited so long as basic or novel characteristics of that which is recited is not changed by the presence of more than that which is recited, but excludes prior art embodiments.
Agarose, as used herein, is a polysaccharide derived from agar.
In accordance with the purpose(s) of the present disclosure, as embodied and broadly described herein, embodiments of the present disclosure, in some aspects, relate to cell plate inserts and systems for cell co-culture.
The present disclosure provides for a cell plate insert including an interior lip (e.g. a support shelf) and legs on a bottom side. The cell plate insert has a diameter to provide a snug fit within a cell plate. Advantageously, the insert can be easily incorporated into standard tissue culture dishes. In some embodiments, the cell plate insert is optically transparent such that the contents of the plate or well can be viewed. In some embodiments, the cell plate insert can be 3D-printed. The cell plate insert can be made from any appropriate biocompatible material, from 3D printing thermoplastics (e.g., Polylactic Acid (PLA), Acrylonitrile Butadiene Styrene (ABS), PolyAmide (PA), High Impact Polystyrene (HIPS), and Thermoplastic elastomer (TPE)), or other materials used in cell culture vessels (e.g., polystyrene, some polycarbonate, stiff resins, glass), or other materials as can be envisioned by one of ordinary skill in the art.
The cell plate insert described herein can offer several advantages over existing technology including: (i) direct visualization of cells during experimentation, (ii) physical separation of the two cell lines to prevent infiltration from the top chamber to the bottom chamber, and (iii) dramatically increased yields of cells, protein, and DNA/RNA for post-experimental analysis.
Embodiments of the present disclosure include a cell plate insert as above having a cell support membrane disposed on the interior lip of the cell plate insert. In various embodiments, the cell support membrane includes agarose, or is made of agarose.
The present disclosure also provides for a system for cell co-culture that includes a cell plate insert, an interior lip on a top side and legs on a bottom side. The cell plate insert can have a diameter to provide a snug fit within a cell plate. In various embodiments, the system can include a cell support membrane that can be disposed on the interior lip of the cell plate insert. The plate insert can have an interior lip to support a cell culture support media. The lip can be on a top side, a bottom side, or both. When the cell support membrane is disposed on the cell plate insert, the cell plate insert forms a top chamber and a bottom chamber, wherein a first cell line can be cultured in the top chamber, and a second cell line can be cultured in the bottom chamber. The cell lines can be the same or different.
The cell culture support media can be an inert, non-cytotoxic matrix forming a membrane (e.g. an agarose membrane, alginate membrane, collagen membrane, hyaluronic acid membrane) that allows for the physical separation of at least two cell lines while still allowing for the chemical communication between the two via length-scale diffusion (
In various embodiments, the cell plate includes a first tissue culture substrate. The cell plate insert can be inserted on top of the tissue culture substrate. In various embodiments, the first tissue culture substrate includes tissue culture plastic (TCP). In some embodiments, the tissue culture substrate can include glass.
In various embodiments, the cell plate insert includes legs that are of a height sufficient to provide an equal distance between the first tissue culture substrate and the cell culture support media. The cell plate insert can have a diameter to provide a snug fit within a cell plate. The snug fit ensures physical separation of the two cell lines to prevent infiltration from the top chamber to the bottom chamber. The number of legs can vary between 3 to about 10 legs, or 4 legs. In some embodiments, the legs can be replaced by a continuous bottom rim. Advantageously, the cell plate allows for oxygen permeability between chambers while preventing cell infiltration.
In a non-limiting embodiment, the cell plate insert can be manufactured to dimensions to accommodate a 10 cm diameter cell plate that is about 13 mm deep. The overall height can be about 10 mm high, including legs that can be about 1 mm to 4 mm, about 1 to 3 or about 2 mm high. The lip can be about 1 mm to 3 mm thick or about 2 mm thick. The lip can be placed about 3 mm below the upper edge of the cell plate insert. Such a configuration can provide a spacing between the first tissue culture substrate on the bottom of the plate and the cell culture support media, wherein the spacing is about 1 mm to about 6 mm, about to 2 mm to about 5 mm, or about 5 mm. The insert can have a diameter of about 95 mm to 99.9 mm, about 96 to about 99 mm or about 95 mm, and the walls of the insert can be about 2 mm to about 6 mm thick, about 2 mm to 5 mm thick, or about 3 mm thick. The lip can project from the interior wall of the cell plate insert sufficient to form support shelf for the cell support membrane. The lip can project about 0.5 to 4 mm, about 1 mm to 3 mm, or about 2 mm. As can be envisioned by one of ordinary skill in the art, these dimensions can be scaled or optimized for use in cell plates of varying sizes.
In another non-limiting embodiment, the cell plate insert can be manufactured to dimensions to accommodate a 36.4 diameter cell plate having a diameter of about 33 mm to 37 mm (e.g. a standard 6-well plate, such as a Corning) that is about 20 mm deep. The overall height can be about 10.15 mm high, excluding legs that can be about 1 mm to 4 mm, about 1 mm to 3 mm or about 2.8 mm high. In some embodiments, the legs can be about 8.8 mm wide The lip can be about 1 mm to 4 mm thick or about 3 mm thick. The lip can be placed about 3 mm below the upper edge of the cell plate insert. Such a configuration can provide a spacing between the first tissue culture substrate on the bottom of the plate and the cell culture support media, wherein the spacing is about 1 mm to about 6 mm, about to 2 mm to about 5 mm, or about 5 mm. The insert can have a diameter of about 28 mm to 35 mm, about 30 to about 34 mm or about 33 mm, and the walls of the insert can be about 1 mm to about 6 mm thick, about 2 mm to 5 mm thick, or about 2 mm thick. The lip can project from the interior wall of the cell plate insert sufficient to form support shelf for the cell support membrane. The lip can project about 0.5 to 4 mm, about 1 mm to 3 mm, or about 2 mm. As can be envisioned by one of ordinary skill in the art, these dimensions can be scaled or optimized for use in cell plates of varying sizes.
In other embodiments, as can be envisioned by one of ordinary skill in the art, the plate can be scaled to fit other sizes or shapes of petri dishes or well plates. Such plates can include but are not limited to small wells such as in 12 well plates or larger petri dishes such as a 15 cm diameter petri dish. In some embodiments, such as for a multi-well plate, the cell plate inserts can be connected such that multiple cell plates can be simultaneously inserted in a multi-well plate.
In various embodiments, the system can include a second tissue culture substrate disposed on top of the cell support membrane.
The system can also include a cell plate lid and/or a base for forming the cell support membrane.
To date, there are no other commercially-available options to perform cellular co-culture experiments beyond the Transwell insert, so there is a significant need for alternative platforms that allow for greater cellular yields for post-experimental analysis. The technology developed in the present disclosure possesses the capabilities to study cell-to-cell communication which can allow for a greater fundamental understanding of how cell-to-cell communication results in the increase or decrease of drug efficacy in clinical trials. The system described herein is user-friendly, cheaper, and allows for dynamic and tunable co-culture conditions while maintaining similar growth patterns as compared to off-chip controls in tissue culture plastic (TCP). Experimental and COMSOL simulations show the rapid diffusion of biomolecules and oxygen across the hydrogel, reaching a steady-state within ˜24 hours. The plate insert was used to study the interactions between three different breast cancer cell lines, triple-negative-MDA-MB-231, HeLa, and ER+(MCF7) co-cultured with adipose-derived stem cells (ASCs). Using this novel co-culture approach, enhanced cellular growth and overexpression of EMT-associated genes were identified in the MDA-MB-231 cell line when they were cultured in the presence of ASCs.
Now having described the embodiments of the disclosure, in general, the examples describe some additional embodiments. While embodiments of the present disclosure are described in connection with the example and the corresponding text and figures, there is no intent to limit embodiments of the disclosure to these descriptions. On the contrary, the intent is to cover all alternatives, modifications, and equivalents included within the spirit and scope of embodiments of the present disclosure.
Currently, neoadjuvant therapies have been identified that target non-cancer cells within the tumor. Examples of this include immunotherapies such as T-cells and PD-1, inhibition of endothelial cell vascular formation through blocking VEGF, or targeting fibroblasts to inhibit matrix production.3 While many adjuvant therapies have been proposed, the complexity of solid tumors and cancer cell-to-cell communication with the surrounding population makes pharmacological intervention complex. In a recent research study by Paino and colleagues, the impact of cancer cells on adipose-derived mesenchymal stem cells (ASCs) was studied by co-culturing ASCs with breast cancer cell line MCF7.4 After 21 days of co-culture study, ASCs triggered angiogenesis with highly vascularized tumor while they did not differentiate; the findings were very significant for the adipose tissue autografting in patients with cancer. Sabol et al. performed another research to examine the relationship between ASCs and MCF7 breast cancer cell line.5 They have demonstrated that the ASCs from obese patients stimulated tumor growth and metastasis in estrogen receptor breast cancer due to increased leptin secretion. Interaction of ASCs and breast cancer studied by Sakurai et al. observed similar results, and they found a calcium-binding protein upregulated six-fold in MCF7 cells when co-cultured with ASCs.6
There is significant interest in gaining a more complete understanding of the intracellular signaling mechanisms driving biomolecule secretion and reception as recent studies have found that cells are phenotypically and genotypically different when cultured alone versus cultured alongside different cell types.7,8 To better understand this paradigm and identify novel neoadjuvant therapies, continual dynamic co-culture of ASCs and cancer cells is required. One approach to study cell-to-cell communication employs conditioned medium.9 This involves culturing one cell line in flaks followed by the collection and transfer of only the media to another cell line in a different flask. While this approach is incredibly easy to use, it is limited to one-way communication and lacks any dynamic interactions between the two cell lines. Therefore cell-to-cell communication is naïve and not representative of a correlative cellular response. Advances on this method include the industry standard for cell-to-cell interactions: co-culture, a process in which more than one cell line is grown in the cell culture dish. The most commonly used technique is the Transwell insert (or Boyden Chamber, Transwell plate).10 This approach utilizes inserts that fit into 24-, 48-, or 96-well plates that contains a polycarbonate membrane to separate two cell lines (
Moreover, Transwell inserts are limited by their ability to collect sufficient cell number for PCR and western blot analysis, two standards in the validation of therapeutic efficacy. Typical cell seeding protocols for Western blot and PCR analysis require cell numbers up to 1-2 million cells per experiment.12 Due to cell density restriction, these numbers are not achievable on the smaller Transwell inserts. Average cell seeding densities on 24-, 48-, and 96-well inserts at maximum cell confluence for standard epithelial and mesenchymal cell lines are 240,000 cells, 120,000 cells, and 40,000 cells respectively.13 This is made further evident by the comparison of obtainable RNA from different cell culture wells and dishes of different sizes (
Recently, microfluidic devices have attempted to address this need by providing an alternative platform for simultaneous co-culture. Byrne et al. developed a microfluidic device based on polydimethylsiloxane (PDMS)-glass to study cell-to-cell signaling using mouse macrophage cells and human kidney cells where diffusion of media occurred across narrow channels that connected the microcompartments.14 The results demonstrated that TNF-α secreted by macrophage stimulated the kidney cells. Ma et al. used a similar microfluidic device consisting of multiple culture chambers interconnected with microchannels to study cell-to-cell communication between fibroblasts and tumor cells.15 Cheng et al. developed an agarose-based microfluidic approach for the study of the chemotactic invasion of HL-60 (neutrophil-like) cells in 2D and dendritic cells in 3D collagen gel.18,17 The major pitfalls of those microfluidic devices encountered shearing formation by the media flow. There are some other groups who developed the co-culture approaches by modifying the existing methods. Thomsen et al. developed an agarose hydrogel-based microwell co-culture platform where breast cancer cells (MDA-MB-231) co-cultured successfully with mesenchymal stromal cells for several weeks.18 They demonstrated the enhanced proliferation in cancer cells, which verifies the exchange of secreted biomolecules between both types of cells through agarose hydrogel while cells remain in the agarose microwell. Agarose also has been used in another co-culture approach described by Young and colleagues in which they seeded cells on a cellulose scaffold and separated distinct cells by agarose layer in a stacked-layer culture model to study the influence of cancer-associated fibroblasts (CAFs) on cancer cells.19 The results indicate that the squamous carcinoma cells increased proliferation and invasiveness due to the stimulation by the CAFs in the new co-culture model. While informative, microfluidic devices suffer from their own limitation. They require external equipment (e.g. pumps) and still suffer from very low RNA yields (less than 1.44 ng/μL).20 Thus, there is a need for a new type of continual co-culture platform that is easy-to-use and allows for very high post-experimental yields of cells, proteins, and DNA/RNA.
The plate insert was designed to create a mass transfer system vertically separated by an agarose membrane in a petri dish. The plate insert is easy to manufacture using a 3D printer, which has led to several design improvements to produce an optimal design (
The mass transfer in the system was first characterized both experimentally and computationally before the plate insert could be utilized for experimentation. Time-dependent mass transfer diffusion studies of oxygen and biomolecules (representing paracrine signals like growth factor or cytokines) were simulated across the agarose barrier to ensure adequate supply for cell growth. A passive diffusion experiment monitoring the mass transfer of 500 kDa FITC(fluoroisothiocynate)-dextran was conducted over a 72 h period, approximately the same duration as culturing experiments. FITC-Dextran molecule was selected for diffusion testing for several reasons: availability/quantity of research on the molecule, similar size to large secreted biomolecules, and ease of quantification. To begin testing, 16 mL of 20 μM FITC-dextran solution was pipetted to the bottom of a petri dish while 16 mL DI water was pipetted on top of the agarose of the Insert. Over the 72 h experiment, samples were drawn at each time point (0, 1, 2, 4, 8, 12, 24, 48, 72 h) and measured absorbance at 488 nm in a NanoDrop® spectrophotometer. The analyzed data (
The 3% (w/v) agarose solution in extracellular buffer (ECB: 5.036 mM HEPES, 136.89 mM NaCl, 2.68 mM KCl, 2.066 mM MgCl2.6H2O, 1.8 mM CaCl2.2H2O, and 5.55 mM glucose) was used to form the agarose membrane into the insert. Before pouring the autoclaved agarose, the base feet of the plate insert were inserted into the circular channel of the mold in the biosafety hood. Then 15 mL of the heated, sterile, liquid agarose solution is pipetted over the mold to create a 2 mm thick membrane. The agarose was allowed to solidify into a circular slab for 30 min. The base mold allowed for a tight seal between the agarose and the insert. This seal is important for both the structural integrity of the agarose and the inhibition of cellular migration. The agarose was next pre-treated with 0.1 mg/mL poly-D-lysine in 1× phosphate-buffered saline (PBS: 137 mM NaCl, 10 mM Na2HPO4, 27 mM KCl, and 1.75 mM KH2PO4 at pH 7.4) to induce cationic charges that facilitate the attachment of the anionically charged cells to the agarose surface. 3 mL of poly-D-lysine solution was incubated on the agarose for 2 hours at room temperature in the biosafety hood. The poly-D-lysine solution was aspirated followed by 5X washing with serum-free culture media. The treated agarose was left in 4° C. overnight before the experiment begins. Single culture experimentation using the 3D-printed plate insert
The poly-D-lysine treated agarose with the plate insert was washed with the cell culture media (DMEM supplemented with 10% v/v HyClone Cosmic Calf Serum, 1% MEM Essential Amino Acids, 1% MEM Non-Essential Amino Acids, 1 mM Sodium Pyruvate, and 6 μL insulin/500 mL media) five times before the cell seeding. Next, one of the two cell lines was seeded with appropriate density on the bottom of the 10 cm culture plate with additional 15 mL of culture media. The plate insert with treated agarose membrane was placed gently into the 10 cm dish, without trapping air bubbles underneath. The second cell line was seeded on the treated agarose followed by the addition 15 mL of cell culture media. Finally, the culture plate lid was placed on top of the dish to maintain sterility. Control single culture experiments were first performed to confirm that cancer cell lines and adipose-derived stem cells (ASCs) behaved the same in the plate insert as they did on traditional tissue culture plastic (TCP). Each cell line was also cultured on separate Petri dishes with or without agarose to evaluate any morphological changes in the novel plate insert co-culture system. The petri dish with agarose was prepared by pipetting 15 mL of the same agarose in a petri dish (TCP) followed by similar poly-D-lysine treatment. All cultures were incubated for 72 h in a humidified incubator (VWR) at 37° C. with 5% carbon dioxide (CO2). Images were collected every 24 h by using a Zeiss Primo Vert phase-contrast microscope equipped with an Axiocam105 color digital camera. All images were further processed in ImageJ (NIH) software and Adobe Illustrator. No change was observed in the growth rate or morphology of triple negative breast cancer cells (MDA-MB-231,
Additionally, terminal viability staining was performed on the MDA-MB-231 cells cultured for 72 hours in the plate insert (
A similar approach to what was described above has been performed under dynamic co-culture conditions. For these initial experiments, MDA-MB-231 cells were cultured on the top agarose layer and ASCs were cultured on the bottom TCP layer. After 72 h of co-culture, both cell lines were collected followed by the successful extraction of cellular DNA and RNA with impressive yields (˜100-400 ng/μL) and purity (A260/A280 values at 2.0) sufficient for both PCR and Western blot analysis. This analysis is currently underway to identify changes in gene expression in both MDA-MB-231 cells and ASCs under dynamic co-culture conditions compared to single culture experiments. Future studies will follow a similar approach; however, they will investigate increased drug resistance in MCF7 cells co-cultured with ASCs.
The 3D-printed plate insert co-culture system described herein possesses the potential to replace the existing Transwell assay for co-culture studies. The system facilitates dynamic co-culture between two cell types without interrupting the viability and morphology of the cells. The plate insert allows bright field imaging during the experiment and delivers a sufficient amount of cells for further analysis, which features make the plate insert unique. Initial counts of collected cells indicate suitable numbers for later gene expression analysis through methods such as PCR and Western Blotting. The COMSOL simulations and experimental FITC-dextran tests confirm sufficient mass transfer across the device and between the two different cell types validating that the desired cellular biomolecules can diffuse through the agarose-insert interface. This system also does not result in the infiltration of cells from the top layer to the bottom (a significant limitation of the Transwell assay) preventing the cross-mixing of cells. This makes the plate insert approach an ideal choice for drug screening and discovery.
Additional information can be found in Appendices A and B.
As indicated above, the majority of microfluidic devices suffer from a few limitations, including (i) an inability to collect/harvest the cells off-chip for post-experimental analysis, (ii) low cell yields, (iii) a require for on-chip interrogation using immunostaining, and (iv) the use of expensive external pumps to infuse the device with media. As such, while microfluidic devices are a powerful tool to perform dynamic co-culture applications, there are certain instances in which a different approach is needed. To address this limitation, a 3D-printed plate insert that incorporates an agarose hydrogel layer to serve as a semi-permeable membrane to create two distinct culture chambers was developed. These two culture chambers, above and below the agarose slab, are physically separated yet chemically connected (
A smaller version of the plate insert described in Example 1 was designed by scaling down the 10 cm diameter to 3 cm diameter to fit into the well of a 6-well plate (Corning, USA). Both inserts and bases were designed using Solidworks (MA, USA) and were fabricated using an Ender-3 Pro 3D printer using a 1.75 mm biocompatible, non-toxic, 3D printing filament (polylactic acid, PLA). The base mold's purpose was to assist in the pouring and solidification of the agarose slab prior to experimentation.
Computational Simulation of Mass Transfer in the Plate Insert Using COMSOL Multiphysics
COMSOL simulations were performed to model the mass transfer of biomolecules and oxygen between the two chambers above and below the plate insert's agarose membrane. The purpose of the model was to ensure that the soluble biomolecules excreted from the cells of one chamber were able to diffuse through the agarose membrane with media to the other chamber cells and validate that the ambient oxygen could reach the bottom chamber to ensure no hypoxic conditions. In the nutrient mass transfer simulation, the property of the media was assumed as water (density 995.6 kg-m−3, viscosity 7.97×10−4 Pa-s) and the diffusion through the media considered the ‘Diffusion of Dilute Species model’ while the diffusion through the agarose layer used ‘Diffusion through Porous Media model’. The porosity of the 3% (w/v) agarose was approximated as 0.971.139 The simulation used the physical properties of 500 kDa fluorescein isothiocyanate (FITC)-dextran to mimic the upper threshold of potential biomolecules that could pass through the agarose membrane. The approximated initial concentration of the FITC-dextran in the bottom chamber was 10 μM. To confirm the proper diffusion of oxygen across the device, the COMSOL model used static ambient air to diffuse through the agarose membrane. The diffusion begins from the agarose membrane at 7 mm height from the bottom of the dish, which is denoted as the z value of 7 at the agarose surface and z=0 at the bottom of the Petri dish.
Experimental Characterization of Mass Transfer in the Plate Insert Using FITC-Dextran
The mass transfer in the system was validated experimentally using a passive diffusion experiment monitoring the mass transfer of 500 kDa FITC-dextran (Sigma, USA) from the bottom chamber to the top chamber over a 72 hours period. To begin testing, 15 mL of 40 μM FITC-dextran solution was pipetted to the bottom chamber of the dish, while 15 mL DI water was pipetted above the agarose in the insert. Samples were collected from the top chamber at nine different time points (0, 1, 2, 4, 8, 12, 24, 48, 72 hours) at five different positions. The samples were then measured for absorbance at 488 nm in a NanoDrop® spectrophotometer (Thermo Fisher Scientific, MA, USA).
Agarose Membrane Preparation
As described in Example 1 for the petri dish insert, the agarose membrane was formed by pouring liquid agarose into the insert in a biosafety hood. The 3% (w/v) agarose solution was prepared and autoclaved, as described in section 2.2.4. The base mold and plate insert were sterilized by immersing them in ethanol before assembly in the biosafety hood. Both the insert and base were left in the hood for ˜1 hour to dry. The insert was locked in a circular channel of the mold before pipetting the hot (−70-80° C.) agarose into it. 15 mL of agarose was pipetted into the mold to produce a 2 mm thick (z-direction) membrane for the 10 cm insert. For uniform surface distribution, 20 mL of agarose was pipetted into the insert, followed by the withdrawal of 5 mL to have 15 mL agarose.
For the 6-well insert, 2 mL of agarose was required to create the membrane. The agarose was allowed to solidify into the circular base slab for 30 minutes in the biosafety hood. The base mold enabled a tight sealing between the agarose and the insert. This seal is essential for the structural integrity of the agarose to prevent the infiltration of cells between the top and bottom chambers. The plate insert was removed from the base mold when the agarose became embedded in the extended lip of the insert. The agarose was then ready for immediate poly-D-lysine treatment or stored at 4° C. for up to 3 days for future treatment. The agarose was treated with 0.1 mg/mL poly-D-lysine (VWR, USA) to induce cationic charges that facilitate the attachment of the anionically charged cells to the agarose surface. In the biosafety hood, 3 mL poly-D-lysine was added to the surface of the agarose for 10 cm insert, while 1 mL of the solution was used for the 6-well insert. The poly-D-lysine solution was incubated on the agarose for 2 hours at room temperature. The poly-D-lysine solution was then aspirated from the agarose, followed by five washes with serum-free DMEM. The plate insert was then wrapped with parafilm and left overnight at 4° C. before the experiment started the next day. Similarly, for a control experiment to compare cell growth on the agarose to cell growth on an insert, the poly-D-lysine treated agarose layer was formed on the bottom of both a 10 cm petri dish and a 6-well plate without the plate insert.
Cell Culture Methods and Reagents
Breast cancer cell lines MDA-MB-231 (triple-negative breast cancer) were acquired from ATCC. All reagents and culture procedures used in this chapter are similar to those described in section 2.2.3. The adipose-derived stem cell donor (ASCs) was Caucasian, female, and 29 years old with a body mass index (BMI) of 32 was obtained from Obatala (New Orleans, La.).
Dynamic Co-Culture Experiments Using the 3D-Printed Plate Insert
Three cell culture experiments were performed, including both experimental and control conditions. Two single cell type control experiments were performed by either (1) directly culturing the cells on the TCP (both the 10 cm dish and the 6 well plates) or (2) adding a slab of agarose onto the bottom of the TCP (both the 10 cm dish and the 6 well plate) and then culturing the cells on top of the agarose. These control experiments were performed to confirm similar growth rates on both surfaces and to ensure the plate insert itself did not alter cell growth. Experimental co-culture conditions involved plating cells on the TCP below the insert (bottom chamber) and the agarose (top chamber). Co-culture experiments involved either the culture of a single cell type in both the top and bottom chamber (e.g., MDA-MB-231 or ASC) or the co-culture of both cell types (MDA-MB-231 in the top chamber and ASCs in the bottom chamber). The single cell line experiments were to investigate the growth rates and transcriptional changes of the cells to confirm that the cells behave the same in the insert as they do on TCP. All agarose surfaces were treated with poly-D-lysine as described above. The poly-D-lysine treated insert was removed from the 4° C. refrigerator, moved to the biosafety hood, and washed five times with the DMEM media (without serum) before the cell seeding. Next, 7.0×105 cells (either 231s or ASCs) in 15 mL of media were added to the TCP plate creating the bottom chamber. The petri dish was gently agitated to facilitate the consistent distribution of cells. The plate insert was then gently placed into the dish using tweezers to ensure no air bubbles formed in the media and agarose membrane interface. If any bubbles were observed in the bottom chamber, they were aspirated. The top culture chamber was then created by adding 10 mL of media containing 7.0×105 cells above the insert. Special care was taken to prevent any media spillage that would lead to cross-mixing between the top and the bottom layer. The entire dish was then rocked gently again to facilitate the uniform distribution of cells. The dish containing the plate insert was placed in the incubator at 37° C. for an hour to settle the cells before collecting ‘0-hour’ images. A similar approach was used for the control experiments using only TCP (Control-TCP) or agarose (Control-Agarose) by adding 15 mL of media containing 7.0×105 cells. The cells were imaged every 24 hours for up to 96 hours using a Zeiss Primo Vert phase-contrast microscope equipped with an Axiocam 105 color digital camera. Cells were harvested at the end of the experiment using the 10 cm insert for subsequent PCR analysis. In brief, the cells were carefully scraped from the top chamber off the agarose slab using a cell scraper, with special care taken to ensure no agarose is lifted during this process. The ˜10 mL media in the top chamber with scraped cells was collected in a 15-mL tube followed by centrifugation at 300 rcf for 5 minutes. Afterward, the supernatant was discarded, and the pellet was re-suspended in 1 mL media and transferred into a 1.5 mL Eppendorf tube followed by centrifugation at 300 rcf for 5 minutes. After centrifugation, the supernatant was aspirated carefully and the pelleted was re-suspended in 50 μL of RNAlater and stored at −20° C. for RNA extraction, followed by PCR analysis. RNA extraction was conducted using Purelink RNA Mini Kit (Life Technologies, USA) via NanoDrop spectrophotometer. A similar approach was used to collect the cells from the bottom chamber after the insert was removed from the dish.
Quantification of Cell Growth in the 6-Well Plate Inserts:
These experiments followed the same setup procedure described above, with the exception of smaller volumes of media and lower numbers of cells. For this experiment, 5.0×104 cells were added to the bottom chamber in 3 mL of media, while 5.0×104 cells were added to the top chamber in 2 mL of media. Cell growth was assessed in triplicate using an Alamar blue assay (Invitrogen, USA) at four time points of 24, 48, 72, and 92 hours. Control experiments were also performed using TCP only and agarose only in the 6 well plates. At each time point, the insert was carefully removed from the culture chamber and placed in an adjacent empty well to allow for interrogation of cells in both the top and bottom layer. This was achieved by aspirating the media from the top chamber followed by the transfer of the insert to the empty well followed by 2 mL of media supplemented with 10% (v/v) Alamar blue. The ‘empty’ neighboring chamber had 3 mL of media in it prior to the addition of the insert to prevent the ‘top’ chamber from drying out during the Alamar blue incubation period. The bottom chamber cells were interrogated by aspirating the 3 mL growth media, followed by adding 2 mL of media containing 10% (v/v) Alamar blue. A similar procedure was performed for the TCP only, and agarose only controls. All well plates were incubated at 37° C. in the dark for four hours. The plates were analyzed using a microplate reader (Perkin Elmer Wallac Victor2, USA) with an excitation of 531 nm and emission of 595 nm. Each observation's fluorescence intensity was normalized to the baseline timepoint at 24 hours by dividing the number of the fluorescence intensity value of each time point by the 24-hour fluorescence value.
Data Analysis: Description of the Statistical Significance
The statistical differences between two groups of single culture and co-culture cells were determined by the student's t-test with a statistically significant value set at p<0.5, using OriginLab software (USA). All data presented in this study is formatted as (mean±standard deviation).
Results and Discussion
COMSOL simulations of biomolecule and oxygen mass transfer across the 3D-printed plate insert—Mass transfer diffusion studies were performed to validate the exchange of biomolecules (e.g. secreted factors by cells) and oxygen across the agarose membrane to confirm both the indirect communication between the cells in both the top and bottom chamber and also to validate that the cells were not experiencing any hypoxic conditions. The first set of simulations focused on the mass transfer of biomolecules from the bottom chamber to the top chamber. These simulations confirmed mass transfer and that a pseudo-steady-state was achieved with ˜24 hours. These simulations used an extremely high weight FITC-dextran molecule (500 kDa) to provide an upper threshold for the type of biomolecules that could be secreted. Typical growth factors are much smaller (˜5-10 kDa), while cytokines and hormones are even smaller. As such, it is anticipated that the diffusion time for these biomolecules will be much lower (˜6-10 hours). Additionally, the simulations did not account for any consumption terms for the biomolecules being processed by the top and bottom chamber cells. However, these studies were sufficient to support the claim that mass transfer did occur between the two culture chambers in the device. The second set of simulations focused on the mass transfer of oxygen into the bottom culture chamber. These simulations were important as many studies with confined chambers to culture cells suffer from reduced oxygen levels leading to hypoxia. For this simulation, the static ambient air was modeled to diffuse through the agarose membrane. The z value of 7 indicates that the diffusion begins from the agarose membrane at the height of 7 mm, which is the total distance from the bottom of the dish (z=0) to the bottom of the agarose slab. An approximate steady-state was observed at ˜8 hours, confirming that the cells in the bottom chamber would not be exposed to the hypoxic condition. Moreover, these simulations assumed that the bottom layer was completely devoid of oxygen at the start of experimentation, which is not the case. As such, these simulations support the claim that oxygen can diffuse through the agarose slab to supply the cell culture in the bottom chamber with sufficient levels for growth and proliferation. As with before, these simulations do not account for the consumption term of oxygen associated with cellular metabolism; however, reaching a pseudo steady state provides sufficient evidence that mass transfer of oxygen does indeed occur with the insert.
Experimental validation of biomolecule mass transfer across the agarose membrane in the 3D-printed plate insert—To supplement the COMSOL simulations, physical experimentation of mass transfer across the agarose membrane was performed. This was achieved by studying the accumulation of a fluorescent molecule in the top culture chamber as a function of time. For this experiment, 40 μM FITC-dextran (500 kDa) in 15 mL of dH2O was added to the bottom chamber in a 10 cm petri dish. The assembled insert was then placed in the dish followed by the addition of 10 mL of dH2O into the top chamber. Five 10 μL samples were collected at five distinct locations in the top culture chamber at nine time points (0, 1, 2, 4, 8, 12, 24, 48, and 72 hours). The relative amount of FITC in the top chamber was determined using a NanoDrop. The data demonstrated that the amount of FITC-dextran in the top chamber increased as a function of time following a logarithmic trend until a stable concentration of ˜40 μM was achieved ˜24 hours (See
Qualitative assessment of MDA-MB-231 cell morphology and viability in the 3D-printed plate insert—It was necessary to confirm that cells grew and behaved the same in the 3D-printed plate insert prior to co-culture experimentation. To achieve this, one experimental and two control conditions were performed using MDA-MB-231 cells. The two control conditions consisted of cells plated directly on the surface of the TCP dish or directly on the surface of agarose that had been layer on the bottom of the TCP dish. The experimental condition consisted of the assembled plate insert where cells were plated on the TCP in the bottom chamber and on the agarose in the top chamber. Images of the cells were collected under each condition to evaluate and compare cellular morphology and approximate changes in cell number. The cells all exhibited the same mesenchymal morphology associated with triple-negative breast cancer cells in the TCP control, the agarose control, and in both chambers of the experimental plate insert experiment. These results are similar to those observed when culturing 231 cells on agarose in a microfluidic device. This finding is also important because any observed changes in cellular behavior (e.g., growth, morphology, genotype) should be due to the presence of a second cell type and not the 3D-printed plate insert. These images also support the notion that the cells were growing in the plates by a relative increase in the number of cells. This qualitative assessment was supplemented with quantitative growth rate studies using Alamar blue (see below). Some efforts were taken to manually count the cells in both the control and experimental conditions to provide some insight into the respective growth rates of the cells. This manual counting approach was both tedious and inconsistent due to human error. As such, the manually counting of cells was abandoned in favor of the Alamar blue approach. In addition to studying cell morphology, a terminal viability stain was performed to confirm that the cells were still alive after 72 hours of culture in the insert. As seen in
RNA qualified the primary purity test while the secondary purity test needs to improve (Table 1).
The RNA yield was also higher in all instances than the required yield of 100 ng/mL.
Quantitative assessment of cell growth in the 3D-printed plate insert—The data presented in the previous section suggested the cells behave the same in the plate insert as in traditional TCP dishes. However, a more quantitative study was needed to confirm similar growth rates across both experimental and control conditions. To accomplish this, a smaller version of the plate insert was designed and fabricated to fit into a 6-well plate. Typical approaches to directly quantify cellular viability and growth utilize fluorescent stains coupled with well plates and a fluorometric plate reader. Alamar blue is one of these stains that functions as a cell health indicator by reduced resazurin (a blue dye) to resorufin (a red dye) in intact, healthy cells. The reduced resorufin is highly fluorescent and proportional to the number of living cells that respire. It is highly sensitive and provides direct information on both cell viability and number growth. In terms of cell growth, the fluorescent signal generated by the Alamar blue assay can be normalized against a baseline value (e.g., the fluorescent signal at 24 hours) to quantify cell growth directly. To investigate cell growth in the 3D-printed plate insert, both experimental and control conditions were repeated in the 6-well plates similar to as described above. Four separate 6-well plates were used for 24-, 48-, 72-, and 96-hour time points because the Alamar blue assay is a terminal assay. Each condition was performed in triplicate to allow for statistical analysis with the average fluorescent signals for each time normalized against the fluorescent signal for the 24-hour time to allow for a direct comparison. As can be seen in
Dynamic co-culture of triple-negative breast cancers with adipose-derived stem cells (ASCs)—Once it was confirmed that the plate insert could support cell growth with no changes in cellular behavior, the final test was to perform dynamic co-culture studies between two cell types. Our prior work demonstrated that the co-culture of MDA-MB-231 triple-negative breast cancer cells with ASCs results in increase growth rates and drug resistance (Rahman et al, 2020). Based on this, we wanted to confirm that both cell types could be cultured using the plate insert. The first experiment performed was a single culture experiment with the ASCs to confirm that their morphology (and indirectly behavior) was not altered due to being cultured on agarose and in the insert. A similar approach was applied here as described above using both TCP and agarose controls and a plate insert experimental condition (
The technology fills a gap in current co-culture approaches in that it provides sufficient cellular yields for traditional biochemical interrogation of cells (e.g., PCR and Western Blot) coupled with the ability to visualize the cells during experimentation continuously. The 3D-printed plate insert is superior to the Transwell assay in many ways, including its ability to harvest cells for downstream analysis, its ability to visualize cells during experimentation, and its ability to prevent cellular invasion from the top chamber into the bottom chamber. The dimensions of two different inserts were optimized to fit in either a 10 cm petri dish or a 6-well plate. Mass transfer (both biomolecules and oxygen) was validated computationally and experimentally to confirm the exchange of paracrine signals between the cell types and that they were not experiencing hypoxia. A series of control experiments were performed to confirm there was no difference in cellular morphology, cellular growth, or cellular viability between the plate insert and TCP/agarose controls. Finally, a proof-of-concept study was performed to demonstrate the ability to co-culture triple-negative breast cancer cells (MDA-MB-231) and ASCs.
It should be noted that ratios, concentrations, amounts, and other numerical data may be expressed herein in a range format. It is to be understood that such a range format is used for convenience and brevity, and thus, should be interpreted in a flexible manner to include not only the numerical values explicitly recited as the limits of the range, but also to include all the individual numerical values or sub-ranges encompassed within that range as if each numerical value and sub-range is explicitly recited. To illustrate, a concentration range of “about 0.1% to about 5%” should be interpreted to include not only the explicitly recited concentration of about 0.1 wt % to about 5 wt %, but also include individual concentrations (e.g., 1%, 2%, 3%, and 4%) and the sub-ranges (e.g., 0.5%, 1.1%, 2.2%, 3.3%, and 4.4%) within the indicated range. In an embodiment, “about 0” can refer to 0, 0.001, 0.01, or 0.1. In an embodiment, the term “about” can include traditional rounding according to significant figures of the numerical value. In addition, the phrase “about ‘x’ to ‘y’” includes “about ‘x’ to about ‘y’”.
It should be emphasized that the above-described embodiments of the present disclosure are merely possible examples of implementations, and are set forth only for a clear understanding of the principles of the disclosure. Many variations and modifications may be made to the above-described embodiments of the disclosure without departing substantially from the spirit and principles of the disclosure. All such modifications and variations are intended to be included herein within the scope of this disclosure.
This application claims the benefit of and priority to U.S. Provisional Application Ser. No. 63/005,836, having the title “SYSTEMS FOR CELL PLATE CO-CULTURE”, filed on Apr. 6, 2020, the disclosure of which is incorporated herein by reference in its entirety.
| Number | Date | Country | |
|---|---|---|---|
| 63005836 | Apr 2020 | US |
